Clinical and Investigative Medicine《临床与研究医学》(可邮箱投稿)

Clinical and Investigative Medicine《临床与研究医学》(季刊). Clinical and Investigative Medicine (CIM), publishes original work in the field of Clinical Investigation. Original work includes clinical or laboratory investigations and clinical reports. Reviews include information for Continuing Medical Education (CME), narrative review articles, systematic reviews, and meta-analyses.

杂志简称:clin invest med
中文译名:《临床与研究医学》
收录属性:scie(2024版), 目次收录(维普), 目次收录(知网),英文期刊,
自引率:12.80%
投稿方向:医学、medicine, research & experimental医学、研究与实验

Clinical and Investigative Medicine《临床与研究医学》

SCI/E期刊基本信息

出版周期:季刊 地区:英国
中科院分区:4区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:非OA期刊
国际标准刊号:ISSN 0147-958X;EISSN 1488-2353
杂志语言:英语
出版国家:英国

杂志官网 联系方式

出版地址:114 CHEYENNE WAY,OTTAWA,CANADA,ON,K2J 0E9
杂志邮箱:
杂志官方网址:https://cimonline.ca/index.php/cim/index
出版商网址:http://www.csci-scrc.medical.org

杂志投稿要求

投稿须知【杂志社官方网站信息】

Authors

Submission Guidelines

Clinical and Investigative Medicine (CIM) publishes original work in the field of Clinical Investigation. Original work includes clinical or laboratory investigations and clinical reports. Reviews include information for Continuing Medical Education (CME), narrative review articles, systematic reviews, and meta-analyses.

Manuscripts, including tables, figures and a covering letter should be submitted by email directly to the Editor in Chief Dr. Robert Bortolussi at Robert.Bortolussi@dal.ca. Do not send zipped files. We will request higher quality files should your submission be accepted.

Manuscript Fees for Authors (Page Charges)

Corresponding Author

Four Pages or Less

Additional Pages

Non Canadian $1500 USD $150 USD

Canadian1 $1500 CAD $150 CAD

CSCI and CITAC Members2 $1000 CAD $100 CAD

1First, corresponding or senior author affiliated to a Canadian institution.

2This rate applies on original research articles with CSCI or CITAC/CIP members as first, corresponding or senior author. Decision on publication acceptance is based on reviewer input.

Manuscript Presentation and Submission

Manuscripts must be prepared and submitted in the manner described in the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journal Editors (2018). In addition, authors should consult the PRISMA Statement when preparing reports of systematic reviews and meta-analyses and the CONSORT Statement when preparing reports of randomized controlled trials.

Authorship and Copyright

Authors must submit a separate covering letter, signed by all authors and including their individual email addresses, stipulating that all persons listed as authors have contributed to preparing the manuscript, and that no person or persons other than the authors listed have contributed significantly in its preparation. Lead/corresponding authors are encouraged to provide an ORCID.

Authors will be asked to transfer copyright of articles accepted for publication to the Canadian Society for Clinical Investigation. The covering letter of submitted manuscripts should be accompanied by letters granting permission to reproduce previously published materials or to use illustrations that may identify subjects.

Please Note: Manuscripts describing investigations carried out on humans will not be accepted for publication unless the text states, at the beginning of the Methods section, that the study has been approved by, and carried out according to the instructions of the author's institutional Human Investigations or Ethics Committee. Reports of investigations on animals will not be accepted for publication unless the text states that the study was approved by the author's institutional Animal Investigation Committee.

Privacy and Confidentiality

Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initial, or hospital numbers should not be published in written description, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.

Style

Manuscripts must be typed, using Microsoft Word, double spaced throughout, including tables and figure legends. Use left justification and 12 point font. Margins should be at least 2.5 cm (1 inch) around.

Each of the following sections must begin on a separate page: Title page, Abstract, Text, Acknowledgements, References, Tables, and Figure Legends. Pages should be numbered consecutively beginning with the title page.

Remember: Figures and Tables must be provided as outlined below.

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/50295

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年11月9日 下午1:01
下一篇 2024年11月9日 下午1:02

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

在线咨询: QQ交谈

邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息